PETNET allies with GlaxoSmithKline

CTI Molecular Imaging subsidiary PETNET Solutions has struck a deal to provide PET isotopes to a GlaxoSmithKline research site. The isotopes will be used for preclinical research. PETNET will have the option, at GSK's discretion, to license diagnostic PET probes developed by GSK. The partnership is in line with PETNET's strategy to develop new proprietary probes that will augment its existing R&D pipeline.